Song Ke

BD Head of Biologics at Shanghai Matwings Technology Co. Ltd

Presenter

Matwings, founded in 2021 by an elite team from Shanghai Jiao Tong University,is one of China's pioneering enterprises in AI-driven protein function prediction and design. The company is dedicated to combining AI technology to provide end-to-end,full-process solutions from protein design, lab validation,and pilot trial to intermediate and commercial-scale production. Matwings independently developed AIACCLBIOTM model, a universal AI platform for protein function prediction, originating from the Venus models developed by Professor Hong Liang’s team at SJTU. This innovation establishes a new paradigm-enabled automated design combined with minimal experimental validation to directly predict protein function instead of via the structure-based model, thus effectively addressing challenges that rely on "expert experience & extensive trial-and-error," including long experimental development, high costs, low positive rates, and difficulties in multi-objective optimization.AIACCLBIOTM significantly enhances protein performance, shortens R&D cycles, reduces development costs, and supports clients in building high-barrier patent portfolios. In just over three years, Matwings has delivered more than 30 protein design projects, highly credited from clients, and established long-term strategic partnerships. Currently, the company's technical services have expanded into multiple downstream fields. The company has been awarded with,including but not limited to,National High-Tech Enterprise,"Specialized, Fine, Special,and New" Small and Medium-sized Enterprise in Shanghai,the "Emerging Enterprise" award for technology entrepreneurship in Minhang District in Shanghai.Matwings has completed three rounds of financing,with investments from star VCs such as Qiming Venture Partners,3E Bioventures Capital, and GSR United Capital.